# Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids

> **NCT00048009** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Dual Integrin Antagonist

## Key facts

- **NCT ID:** NCT00048009
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10-25
- **Primary completion:** 2004-02-02
- **Final completion:** 2004-02-02
- **Target enrollment:** — (—)
- **Last updated:** 2017-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048009, "Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00048009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*